Showing results (651-660 of 3,171) with videos related to

Sort By:
Pageof 318
Translational Oncology|March 4, 2026
Development and characterization of anti-CXCR4 chimeric antigen receptor T cellsGabriel Seir, Quenton Rashawn Bubb, Elena Sotillo, et al.
Translational Oncology|December 14, 2024
UGCG promotes chemoresistance and breast cancer progression via NF-κB and Wnt/β-catenin pathway activationLi Long, Lei Wang, Yiran Liang, et al.
Translational Oncology|February 20, 2024
Polyene phosphatidylcholine enhances the therapeutic response of oxaliplatin in gastric cancer through Nrf2/HMOX1 mediated ferroptosisPeijie Lei, Lianjing Cao, Hongjun Zhang, et al.
Translational Oncology|February 22, 2024
Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinomaXu Chen, Bo Sun, Yu Chen, et al.
Translational Oncology|March 27, 2024
A regionally based precision medicine implementation initiative in North Africa:The PerMediNA consortiumYosr Hamdi, Maroua Boujemaa, Jihenne Ben Aissa-Haj, et al.
Translational Oncology|March 15, 2024
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cellsYifat Koren Carmi, Abed Agbarya, Hazem Khamaisi, et al.
Translational Oncology|February 18, 2024
HNRNPL facilitates ferroptosis in hepatocellular carcinoma cells by promoting S100A9 expressionLanfang Yang, Zhibo Zhang, Xiangqing Yao, et al.
Translational Oncology|February 24, 2024
CT-guided high dose rate brachytherapy can induce multiple systemic proteins of proliferation and angiogenesis predicting outcome in HCCLukas Salvermoser, Shraga Nahum Goldberg, Marianna Alunni-Fabbroni, et al.
Translational Oncology|January 31, 2024
The role of tertiary lymphoid structure and B cells in nasopharyngeal carcinoma: Based on bioinformatics and experimental verificationChujun Chen, Yan Zhang, Xiaoting Wu, et al.
Translational Oncology|July 30, 2023
ABCB11 accumulated in immature tertiary lymphoid structures participates in xenobiotic metabolic process and predicts resistance to PD-1/PD-L1 inhibitors in head and neck squamous cell carcinomaJunya Ning, Jie Hao, Fengli Guo, et al.
Pageof 318